Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 808 entries
View as:

Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03170206 Org: User:
Start: 05/31/17 End: 12/31/25 Due: 12/31/26

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02795858 Org: User:
Start: 06/14/16 End: 12/31/23 Due: 12/31/24

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02865135 Org: User:
Start: 03/30/17 End: 02/06/23 Due: 02/06/24

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03333616 Org: User:
Start: 12/28/17 End: 05/31/26 Due: 05/31/27

Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

Phase: N/A Priority: Normal
NCT ID: NCT05327452 Org: User:
Start: 10/31/22 End: 12/31/25 Due: 12/31/26

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT01085201 Org: User:
Start: 04/30/10 End: 03/31/13 Due: 03/31/14

Everolimus for Cancer With TSC1 or TSC2 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02201212 Org: User:
Start: 09/30/14 End: 06/30/19 Due: 06/30/20

Preoperative Herceptin and Navelbine for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00148681 Org: User:
Start: 05/31/01 End: 05/31/03 Due: 05/31/04

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00139230 Org: User:
Start: 01/31/97 End: 12/31/06 Due: 12/31/07

The Young Women's Breast Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT01468246 Org: User:
Start: 11/30/06 End: 01/31/26 Due: 01/31/27

Sargramostim (GM-CSF) + PD-1

Phase: N/A Priority: Normal
NCT ID: NCT04703426 Org: User:
Start: 04/16/21 End: 06/09/25 Due: 06/09/26

GDC-0084 in Combination with Trastuzumab for Patients with HER2-Positive Breast Cancer Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03765983 Org: User:
Start: 02/11/19 End: 11/30/25 Due: 11/30/26

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00020618 Org: User:
Start: 03/31/01 End: 02/29/04 Due: 02/28/05

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00047294 Org: User:
Start: 04/30/01 End: 09/30/07 Due: 09/30/08

Educational Interventions for Patients With DCIS

Phase: N/A Priority: Normal
NCT ID: NCT00148655 Org: User:
Start: 05/31/03 End: 08/31/06 Due: 08/31/07

A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

Phase: N/A Priority: Normal
NCT ID: NCT02268851 Org: User:
Start: 11/30/14 End: 10/31/22 Due: 10/31/23

Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02670525 Org: User:
Start: 08/17/16 End: 01/31/28 Due: 01/31/29

Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00684411 Org: User:
Start: 06/30/08 End: 10/31/13 Due: 10/31/14

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

Phase: N/A Priority: Normal
NCT ID: NCT06040125 Org: User:
Start: 01/01/24 End: 02/28/27 Due: 02/28/28

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03065062 Org: User:
Start: 02/28/17 End: 01/31/26 Due: 01/31/27

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Phase: N/A Priority: Normal
NCT ID: NCT01796197 Org: User:
Start: 08/31/13 End: 11/30/25 Due: 11/30/26

A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT03187262 Org: User:
Start: 11/27/17 End: 12/31/21 Due: 12/31/22

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00165347 Org: User:
Start: 12/31/03 End: 10/31/06 Due: 10/31/07

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02689401 Org: User:
Start: 05/31/16 End: 05/31/16 Due: 05/31/17

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Phase: N/A Priority: Normal
NCT ID: NCT03534323 Org: User:
Start: 07/12/18 End: 07/01/26 Due: 07/01/27